Sandra Agik, M.S.

Senior Associate

Sandra Agik, M.S., a Senior Associate at Dobson | DaVanzo, brings a broad range of experience in conducting clinical research, epidemiological analyses, and survey design to the firm. Joining in 2020, Ms. Agik works with a variety of commercial and government  clients to evaluate the market-, state- and national-level effects of existing and proposed healthcare payment reforms. Primarily, she collaborates with clients to understand their specific research needs and works with the D|D team of analysts and data scientists to develop and execute rigorous analytic approaches to answering clients’ questions. For example, Ms. Agik recently conducted predictive analyses using machine learning techniques, such as LASSO and XGBoost models to identify risk factors for future client opioid misuse and overdose events.

At Dobson | DaVanzo, Ms.Agik is currently supporting research and developing summary reports and visualizations on Medicaid damages due to the opioid pandemic incurred by a state Medicaid program. She is also conducting statistical analyses, constructing visualizations, and co-developing the Final Report for a Centers for Medicare and Medicaid Services (CMS) project to provide technical support to the Agency in administering the Part C and Part D programs. She previously conducted research and analyses to assess the Impact of the Patient-driven Grouping Model (PDGM) on Home Health using CY2020 Medicare home health care claims data.

Prior to Dobson | DaVanzo, Ms. Agik worked as a Senior Analyst at the Advisory Board where she conducted qualitative and quantitative best practice research to generate insights for Healthcare Executives across the nation. Ms. Agik served on the Post-Acute Care Research Collaborative where she supported numerous analyses of Medicare FFS claims data to generate business strategy and insight concerning post-acute care clinical pathways and later to benchmark performance on key quality metrics. Ms. Agik also served on the Health Plan Advisory Council where she led the firm’s strategic research guiding Medicare Advantage Health Plans in launching newly allowed supplemental benefits.

As an undergraduate Ms. Agik served as a research assistant in Dr. Timothy Niewold’s genetics lab and investigated the genetic association between UBE2L3 gene and Systematic Lupus Erythematous (SLE) in African American patients. Ms. Agik investigated the risk of UBE2L3 gene in Systematic Lupus Erythematosus in African American patients using single nucleotide polymorphism (SNP) genotyping methods for a patient cohort of 252 and matched controls. She published results in the Journal of Rheumatology. (March 2012)

Post-baccalaureate, Ms. Agik continued to conduct clinical research as a Clinical Research Associate at the Center for Clinical Cancer Genetics at the University of Chicago, where she coordinated and managed several interventional cancer research studies. Ms. Agik led the start-up of a multi-site study to return research genetic panel testing results by telephone/video conferencing to women at increased risk for breast cancer who had previously donated samples for research purposes. Ms. Agik also monitored and managed two federally funded clinical trials for subjects diagnosed with hereditary breast and ovarian cancer syndrome and those at high risk of developing breast cancer with study sites in Nigeria, Uganda and the U.S.

During her graduate program at Brown University Ms. Agik coordinated and managed several epidemiological studies. At the Rhode Island Hospital’s Emergency Department, Ms. Agik coordinated a multi-site clinical study on HIV/AIDS literacy and monitored study data for completeness, accuracy and consistency. Ms. Agik also conducted phone interviews to assess participant satisfaction with study-provided HIV-self test kits. During a summer internship at the Dana Farber Cancer Institute, Ms. Agik planned and conducted a quality improvement research project to streamline the abstraction of clinical and treatment data from hospital electronic medical records to annotate longitudinal outcomes of patients.

Ms. Agik holds a Bachelor of Arts degree in Biological Sciences from the University of Chicago and a Master of Science degree in Epidemiology from Brown University. Ms. Agik is a recipient of numerous honors and awards including the Jeff Metcalf Fellowship Summer Grant ( 2012-2013), the Aga Khan Foundation International Scholarship (2015-2017), and the Minority Training Program in Cancer Control Research Summer Institute Fellowship (2016).                                                                                                                                                         

Go Back